FCC Simplifies Process To Access Wireless Spectrum For Device Clinical Trials
This article was originally published in The Gray Sheet
A Federal Communications Commission regulation establishes a medical testing license for health care facilities wishing to host human trials for medical devices with wireless capability.
You may also be interested in...
Infrastructure for evaluating the wireless properties of medical devices will be the subject of a joint FDA and Federal Communications Commission workshop scheduled for March 31.
An HHS-sponsored workgroup issued its initial recommendations for a health IT regulatory framework, featuring risk-based oversight, adverse event reporting and better agency coordination.
In a petition to the Federal Communications Commission, Medtronic asked the agency to expand medical testing license eligibility to sponsors of clinical trials, as well as clarify its policy on manufacturers recovering costs for clinical studies.